“…A number of imaging technologies are currently available to evaluate lung inflammation but the application of these techniques to allergic inflammation is limited. For example, 18 F-fluorodeoxyglucose, in conjunction with positron emission tomography (PET), is commonly used to assess increased glucose uptake, and therefore metabolism, as a surrogate of inflammatory cell activity [14]. Unfortunately, this technique has not been shown to be a useful assessment of airway inflammation in asthmatics [15], unless under conditions of a segmental allergen challenge [16,17], most likely because neutrophils, a cell-type with a debatable association to allergic asthma, use more glucose than other cell types when activated [18,19].…”